Malignant Thymus Neoplasm — Trials

Malignant Thymus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 80
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 23%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04358458	First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas	terminated	Phase 1 / Phase 2	46	GenmabINDUSTRY	5	Oct 24, 2024	clinicaltrials
NCT04925947	A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors	terminated	Phase 2	4	Weill Medical College of Cornell UniversityOTHER	1	Apr 16, 2024	clinicaltrials